Hikmet A. H.
- Country
- Czechia
- Department
- Klinika kardiologie
Research Overview
- Phase Ib Dose-Ranging Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of HS235 Versus Placebo in Combination with Background Therapy in Pulmonary Arterial Hypertension
- Phase 2 Study of REGN13335 Efficacy and Safety in Adults with Pulmonary Arterial Hypertension
- Efficacy and Safety of IKT-001 in Adults with WHO Group 1 Pulmonary Arterial Hypertension: An Adaptive, Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 88 of 138 partner sites.
Specializations
Pulmonary Vascular Disorders
This investigator specializes in treating pulmonary arterial hypertension (PAH), with particular focus on developing innovative therapeutic approaches for this challenging cardiovascular condition.
- Advanced PAH Treatment Modalities
- Novel Therapeutic Agents
- Long-term Disease Management
Their research extends to evaluating both oral and inhaled medication delivery systems for PAH treatment.
Heart Failure Complications
The investigator conducts research in heart failure and associated pulmonary hypertension, specifically focusing on WHO Group 2 classification disorders.
- Pulmonary Vascular Resistance
- Left Heart Disease
- Cardiovascular Hemodynamics
Their work includes evaluation of therapeutic interventions for complex cardiopulmonary conditions.
Treatment Innovation
The investigator explores novel therapeutic compounds and their applications in cardiovascular medicine, with emphasis on breakthrough treatments for pulmonary vascular diseases.
- Emerging Drug Development
- Clinical Efficacy Assessment
- Safety Profile Evaluation
Their research encompasses both established and experimental treatment approaches for cardiovascular conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.